Free
Meeting Abstracts  |   April 2005
Differential Effects of Bupivacaine and Ropivacaine Enantiomers on Intracellular Ca2+Regulation in Murine Skeletal Muscle Fibers
Author Affiliations & Notes
  • Wolfgang Zink, M.D., D.E.A.A.
    *
  • Goetz Missler, M.S.
  • Barbara Sinner, M.D.
    *
  • Eike Martin, M.D.
  • Rainer H. A. Fink, Ph.D.
    §
  • Bernhard M. Graf, M.D., Ph.D.
  • * Assistant Professor, Department of Anesthesiology and Institute of Physiology and Pathophysiology, † Senior Medical Student, ‡ Professor and Chair, ∥ Professor and Vice Chair, Department of Anesthesiology, § Professor, Institute of Physiology and Pathophysiology.
Article Information
Meeting Abstracts   |   April 2005
Differential Effects of Bupivacaine and Ropivacaine Enantiomers on Intracellular Ca2+Regulation in Murine Skeletal Muscle Fibers
Anesthesiology 4 2005, Vol.102, 793-798. doi:
Anesthesiology 4 2005, Vol.102, 793-798. doi:
LOCAL anesthetic–induced myotoxicity seems to be a rather uncommon side effect of local and regional anesthesia.1 However, recent studies revealed that certain anesthesia techniques—especially retrobulbar and peribulbar blocks—are related to a relatively high postoperative rate of significant muscular dysfunction directly caused by these agents.2 Therefore, skeletal muscle damage has to be considered a potentially serious complication after local anesthetic application.
Intramuscular injections of local anesthetics regularly result in striated muscle damage and myonecrosis, with an agent-specific and dose-dependent rate of toxicity.3–5 In this respect, hypercontracted myofibrils are the first histologic signs to become evident several minutes after injection, followed by lytic degeneration of striated muscle sarcoplasmic reticulum (SR), myocyte edema, and myonecrosis over the next hours. Intriguingly, myoblasts, vasculature, and basal laminae are not affected, and therefore, tissue regeneration may be ensured within 2–4 weeks.6 Subcellular pathomechanisms of local anesthetic myotoxicity are still not completely revealed in detail. However, Benoit et al.  suggested that excessively increased intracellular Ca2+concentrations play a key role in myocyte injury, inducing numerous pathways of cell death.7,8 
In previous studies, we showed that bupivacaine as well as ropivacaine destroy skeletal muscle fibers at the injection site, with ropivacaine being characterized by a significantly lower rate of myotoxicity in comparison with bupivacaine.8 These findings can be explained by the specific effects of both agents on intracellular Ca2+regulation: Bupivacaine and—to a smaller extent—ropivacaine both induce Ca2+release from the SR and simultaneously inhibit Ca2+reuptake into the SR, resulting in persistently increased Ca2+concentrations.9–11 
However, in these studies, myotoxic effects of the clinically applied preparations of both local anesthetics (i.e.  , racemic bupivacaine and pure S  (−)-ropivacaine) have been experimentally assessed, and the observed differences theoretically may have been the result of stereoselective effects or different lipophilicity. Therefore, the current study was conducted to assess the influence of stereoselectivity and lipophilicity on alterations of myocyte Ca2+regulation using the well-established model of skinned murine skeletal muscle fibers.
Materials and Methods
With approval of the Institutional Animal Care Committee of the University of Heidelberg (Heidelberg, Germany), we chose the well-established model of murine skinned fiber preparations, using an experimental protocol described before.9,12–14 Altering the composition of respective experimental solutions, this model ensures the clear assessment of specific local anesthetic effects on both Ca2+release from the SR and on gross Ca2+reuptake.
Experimental Solutions
Table 1summarizes the ionic concentrations of the different basic experimental solutions. All solutions were adjusted to a pH of 7.0 and contained 60 mm HEPES buffer, 8 mm adenosine triphosphate, and an adenosine triphosphate–regenerating system consisting of 10 mm creatine phosphate and 150 U/l creatine kinase. In addition, all solutions contained 66 mm K+, 36 mm Na+, and 0.4 mm Mg2+(free ion concentrations).
Table 1. Experimental Solutions 
Image not available
Table 1. Experimental Solutions 
×
The high activating solution (HAS; 24.9 μm Ca2+), and the high relaxing solution (HRS; without Ca2+) included 30 mm EGTA with a high affinity to Ca2+for “clamping” the free Ca2+concentration. In contrast, the low relaxing solution (LRS; without Ca2+) included 0.3 mm EGTA but 29.7 mm HDTA with a very low affinity to Ca2+ions. Free ionic concentrations and the ionic strength of all solutions (Γ/2 = 157 mm at a pH of 7.00 and 23.0°C) were calculated using the REACT program by Smith and Miller.15 
The skinning solution was obtained by adding saponin (50 μg/ml) to the LRS, and the loading solution (LS; 0.41 μm Ca2+) was obtained by mixing equal volumes of HAS and HRS. The release solutions (RSs) consisted of LRS with caffeine (10 mm) or with pure R  - enantiomers, pure S  -enantiomers, or racemic mixtures of bupivacaine and ropivacaine, respectively (AstraZeneca Laboratories, Södertalje, Sweden).
To assess the [Ca2+]–force relation, HAS and HRS were appropriately mixed to obtain six different concentrations (0.41, 0.62, 0.96, 1.62, 3.39, and 24.9 μm) of free [Ca2+].
Fiber Preparation and Experimental Protocol
BALB/c mice were exposed to carbon dioxide before being killed during deep anesthesia by cervical dislocation. Subsequently, the extensor digitorum longus muscle, which predominantly consists of fast-twitch fibers (> 95%), was carefully dissected and stored in paraffin oil at 4°C.12–14 Subsequently, a fiber bundle consisting of one to three single muscle cells (diameter between 70 and 150 μm) was isolated and glued to a force transducer recording system (based on AE 801; SensoNor A.S., Horten, Norway) and to a micrometer-adjustable metal pin. Analyzing the diffraction pattern of a helium–neon laser beam the sarcomere length was adjusted to 2.6 μm.9,12–14,16 
At the beginning of each experiment, the fibers were placed in the skinning solution for 5 min. After the skinning procedure, the fiber was dipped for 5 s into the RS to unload the SR, for 5 s into the HRS, and for 2 min into the LRS for equilibration. Then, the fibers’ SRs were loaded with Ca2+for 40 s in the LS, and subsequently, the preparations were dipped into the HRS for 5 s before transferring them again into the LRS for 2 min. In the following, the fibers were exposed to the respective RS, and the force transient induced by 10 mm caffeine was recorded. Finally, the maximal force transient was measured in the HAS at 24.9 μm Ca2+. Because saponin skinning may reduce the Ca2+loading capacity of the SR and to control the permeabilization procedure of the fibers, the initial caffeine release had to be at least 30% of maximal force; otherwise, the preparation was discarded.
To investigate the ability of all tested agents to induce Ca2+release from the SR, the Ca2+loaded fibers were exposed to a “modified” RS containing respective isomers or racemates, respectively, but no caffeine. Subsequently, all local anesthetic isomers and racemates were added to the LS, and force transients were measured after transferring the preparations into RSs containing caffeine alone. Finally, control measurements in the absence of all tested agents were performed to demonstrate the return to baseline.
At the end of the experimental protocol, individual [Ca2+]–force relations were assessed for each fiber at different Ca2+concentrations.17 These measurements were performed without any addition to the solutions, with caffeine, and with bupivacaine and ropivacaine isomers and racemates, respectively (table 2).
Table 2. Experimental Protocol 
Image not available
Table 2. Experimental Protocol 
×
Throughout this protocol, all measurements were performed at four different concentrations of the agents (1, 5, 10, and 15 mm). Two to four fiber bundles per animal were dissected, and six fiber bundle preparations per agent were examined at each concentration level.
Data Analyses and Statistics
All force transients were normalized to the corresponding maximum force at 24.9 μm Ca2+. [Ca2+]–force relations representing the individual Ca2+sensitivity of the contractile apparatus were quantified by fitting a Hill curve to the measured data points.17 Each curve is characterized by the Hill coefficient (n) as an indicator of maximal steepness of the sigmoid graph and the pCa50value (negative decadal logarithm of [Ca2+] at which isometric force is half maximal) as an indicator of Ca2+sensitivity of the contractile apparatus. For each fiber, the characteristic n and pCa50values were used to transform force transients into free myoplasmic Ca2+transients according to an algorithm described by Uttenweiler et al.  18 
For statistical analysis, the Kolmogorov-Smirnov test to confirm normal distribution for each group, one-way analysis of variance, and the Student t  test with Bonferroni correction. All P  values were two tailed and were considered significant at 0.05 or less. All data are presented as mean ± SD.
Results
Ca2+Release from the Sarcoplasmic Reticulum
The force transients induced by the tested isomers and racemates are shown in figure 1A. Using fiber-specific n and pCa50values, these transients have subsequently been transformed into corresponding Ca2+transients (fig. 1B): R  -ropivacaine, S  -ropivacaine, and racemic ropivacaine dose-dependently induced Ca2+transients, whereas the effects of racemic ropivacaine were markedly stronger than those of the R  -enantiomer but less pronounced than those of the S  -isomer.
Fig. 1. (  A  ) Mean force transients induced by the optical isomers and racemates of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. All force transients are normalized to maximum force transient at 24.9 μm Ca2+. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients induced by tested local anesthetics (  fig. 1A) into corresponding Ca2+transients, based on the individual [Ca2+]–force relation of each fiber. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 1. (  A  ) Mean force transients induced by the optical isomers and racemates of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. All force transients are normalized to maximum force transient at 24.9 μm Ca2+. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients induced by tested local anesthetics (  fig. 1A) into corresponding Ca2+transients, based on the individual [Ca2+]–force relation of each fiber. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 1. (  A  ) Mean force transients induced by the optical isomers and racemates of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. All force transients are normalized to maximum force transient at 24.9 μm Ca2+. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients induced by tested local anesthetics (  fig. 1A) into corresponding Ca2+transients, based on the individual [Ca2+]–force relation of each fiber. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
×
Analogously, the dose-dependent effects of R  -bupivacaine on Ca2+release from the SR were smaller than those of the racemate, and again, the S  -isomers showed the strongest effects on Ca2+release.
At the concentrations of 5, 10, and 15 mm, S  -bupivacaine was more potent than S  -ropivacaine, whereas racemic bupivacaine was more potent than racemic ropivacaine at some concentrations but not at others. Similarly, R  -bupivacaine was more potent than R  -ropivacaine at some concentrations but not at others.
Ca2+Reuptake into the Sarcoplasmic Reticulum
Figure 2Ashows caffeine-induced force transients after Ca2+loading in the presence of all tested agents. Again, these transients have been transformed into corresponding Ca2+transients with the help of fiber-specific n and pCa50values (fig. 2B): The presence of R  - ropivacaine, S  -ropivacaine and racemic ropivacaine (5, 10, and 15 mm) during the loading procedure dose-dependently decreased caffeine-induced Ca2+transients.
Fig. 2. (  A  ) Caffeine-induced force transients after loading in the presence of the racemates and isomers of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. In comparison with control transients, all tested agents in concentrations of 5 mm or greater significantly decreased force transients (except  R  -bupivacaine at 5 mm; bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients (  fig. 2A) into corresponding [Ca2+] transients. Again, all tested isomers and racemates, respectively, in concentrations of 5 mm or greater significantly decreased caffeine-induced Ca2+transients in comparison with control values (bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 2. (  A  ) Caffeine-induced force transients after loading in the presence of the racemates and isomers of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. In comparison with control transients, all tested agents in concentrations of 5 mm or greater significantly decreased force transients (except  R  -bupivacaine at 5 mm; bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients (  fig. 2A) into corresponding [Ca2+] transients. Again, all tested isomers and racemates, respectively, in concentrations of 5 mm or greater significantly decreased caffeine-induced Ca2+transients in comparison with control values (bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 2. (  A  ) Caffeine-induced force transients after loading in the presence of the racemates and isomers of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. In comparison with control transients, all tested agents in concentrations of 5 mm or greater significantly decreased force transients (except  R  -bupivacaine at 5 mm; bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients (  fig. 2A) into corresponding [Ca2+] transients. Again, all tested isomers and racemates, respectively, in concentrations of 5 mm or greater significantly decreased caffeine-induced Ca2+transients in comparison with control values (bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
×
At the concentrations of 5, 10, and 15 mm, S  -enantiomers of both ropivacaine and bupivacaine were more potent than the corresponding R  -enantiomers. In addition, racemic ropivacaine was more potent than R  -ropivacaine at some concentrations, but in contrast, the effects of racemic bupivacaine were not different from those of R  -bupivacaine.
When compared with the corresponding enantiomers, R  -bupivacaine was more potent than R  -ropivacaine at 5 and 15 mm but not at 10 mm. However, at all tested concentrations, there was no significant difference between racemic bupivacaine and racemic ropivacaine. In addition, S  -bupivacaine was more potent than S  -ropivacaine at 5 mm but not at 10 or 15 mm.
According to our experimental protocol, another control measurement was performed after these experiments, to exclude long-term effects of after washout. There was no significant difference between these force transients and the transients assessed at the beginning of our protocol (data not shown graphically).
Ca2+Sensitivity and Hill Coefficient Values
Changes in pCa50values are displayed in figure 3A, representing alterations in Ca2+sensitivity of the contractile apparatus in the presence of the tested agents. In comparison with control measurements, there was a dose-dependent increase in pCa50after exposure to all examined local anesthetics. Changes in Hill coefficients are shown in figure 3B. These values decreased in a dose-dependent way in the presence of all local anesthetics, with effects being most pronounced at concentrations greater than 5 mm. However, with regard to changes in both parameters, no obvious differences between the experimental groups were found.
Fig. 3. (  A  ) pCa50values (representing Ca2+sensitivity of the contractile apparatus), assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. No significant differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Hill coefficients n, assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. Again, no obvious differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 3. (  A  ) pCa50values (representing Ca2+sensitivity of the contractile apparatus), assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. No significant differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Hill coefficients n, assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. Again, no obvious differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 3. (  A  ) pCa50values (representing Ca2+sensitivity of the contractile apparatus), assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. No significant differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Hill coefficients n, assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. Again, no obvious differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
×
Discussion
An excessive increase in intracellular Ca2+concentrations has been revealed to be an important mechanism in local anesthetic myotoxicity.7 In this respect, highly myotoxic (racemic) bupivacaine has recently been identified to induce Ca2+release from the SR and to inhibit Ca2+reuptake simultaneously.9,19 To a minor extent, however, the clinically used pure optical S  -isomer of ropivacaine, which is characterized by a more moderate rate of myotoxicity in vivo  , also induces Ca2+release from the SR and inhibits reuptake.8,10,11 In theory, these obvious differences between toxic potencies might be the result of stereoselective effects on intracellular Ca2+homeostasis or of the different lipophilicity of both agents. Therefore, the current study was conducted to assess the impact of stereoselective effects and lipophilicity of local anesthetics on Ca2+regulation by the SR in murine striated myocytes. Testing the pure optical isomers as well as the racemates of ropivacaine and bupivacaine, respectively, we found out that all agents induce Ca2+release from the SR and inhibit Ca2+reuptake. However, S  -enantiomers in general seemed significantly more effective than R  -enantiomers, with intermediate effects of racemic mixtures.
Optical isomers, with the exception of rotation of the plane of light, share all physicochemical properties but have an asymmetric carbon atom. Because S  -isomers of long-acting pipecoloxylidide derivatives have been recognized to be less cardiotoxic, S  -ropivacaine and levobupivacaine (S  -bupivacaine) have recently been introduced into clinical practice.20 Although both levobupivacaine and ropivacaine are pure optical S  -isomers, the butyl group of bupivacaine is replaced by a propyl group for ropivacaine. This change of molecular structure affects major physicochemical characteristics, such as molecular weight and lipophilicity, while not significantly affecting the pKa value.20 In addition, both local anesthetics are characterized by similar pharmacokinetic profiles on protein binding and metabolism. Differences between the isomers of the anesthetics are caused by stereoselective binding of the isomers to the target site, which itself must be optically active.20 
To systematically assess effects on intracellular Ca2+regulation of striated myocytes, the pure optical isomers as well as the racemates of bupivacaine and less lipophilic ropivacaine, respectively, were examined in concentrations of 1, 5, 10, and 15 mm. With special regard to local anesthetic myotoxicity, these obviously high concentrations were necessary to simulate direct exposure of the myocytes to these agents in clinically relevant concentrations (15 mm = 0.5% bupivacaine solution).1,9 As an experimental approach, we have chosen the well-established model of saponin-skinned murine muscle fibers to obtain direct information about the effects of ropivacaine and bupivacaine isomers on intracellular Ca2+regulation by the SR and on Ca2+sensitivity of the contractile proteins. In this experimental setup, isometric force transients are directly measured and mathematically transformed into corresponding intracellular Ca2+transients.12–14,17,18 This procedure is possible because several studies on intracellular Ca2+distribution using fluorescence microscopy and digital image analysis have shown that because of the fast Ca2+binding kinetics of troponin C, the time course of caffeine-induced force transients occurs under quasi–steady state conditions for intracellular Ca2+concentrations and force.14,21,22 Nevertheless, methodologic limitations of this model must be mentioned because intracellular [Ca2+] is not directly determined but only inferred from mechanical transients. It remains undetermined whether our results can be entirely transferred to slow-twitch fibers because fast-twitch fibers are predominant in murine extensor digitorum longus muscles.12–14 However, marked differences between local anesthetic effects on both fiber types are not expected to be probable.12–14,17,21 
In the current study, we found out that all tested local anesthetics dose-dependently induce Ca2+release from the SR, inhibit Ca2+reuptake (indicated by significantly decreased caffeine induced transients after loading in the presence of these agents), and sensitize the contractile apparatus to free Ca2+. However, despite qualitative similarities in these effects on intracellular Ca2+regulation, there were marked quantitative differences: At least in concentrations of 5 mm or greater, the effects of S  -isomers of ropivacaine and bupivacaine on Ca2+release and reuptake were significantly more pronounced than those of corresponding R  -enantiomers, with intermediate effects of racemates in equimolar concentrations. These data prove that stereoselectivity is involved in local anesthetic effects on intracellular Ca2+homeostasis in murine striated myocytes. According to the results of previous examinations, these alterations in myocyte Ca2+regulation could be explained by direct interactions of local anesthetic isomers with the Ca2+release channel ryanodine receptor (RyR) as well as with Ca2+–adenosine triphosphatases of the SR9,19,23 : Three forms of RyR have been identified, whereas RyR1 is expressed predominantly in skeletal muscle fibers.24 Numerous agents have been shown to activate RyR1 and thus to induce Ca2+release from the SR by increasing the opening probability of this receptor complex, but to our knowledge, no stereoselective effects on RyR1 have been described.24 In contrast to RyR1 activation, stereoselectivity has been shown to be involved in the inhibition of SERCA adenosine triphosphatases by thapsigargin derivatives.25 However, despite the fact that our current data clearly indicate stereoselective interactions of ropivacaine and bupivacaine isomers with both SR channels, basic molecular mechanisms of these observations remain unrevealed because our experimental setup is not suitable to clear this issue.
Another result of this experimental study was that the effects of highly lipophilic bupivacaine isomers on Ca2+release were significantly more distinct than those of corresponding ropivacaine isomers in identical concentrations. In contrast, no significant differences were found between bupivacaine and ropivacaine enantiomers with regard to the inhibition of Ca2+reuptake and to changes in Ca2+sensitivity of the contractile apparatus, respectively. Therefore, next to stereoselectivity, we suggest that physicochemical properties of local anesthetics, particularly the specific lipophilicity, may also determine the extent of Ca2+release from the SR in skeletal muscle fibers. Again, molecular mechanisms of these observations remain unrevealed.
In conclusion, we have shown that stereoselectivity is involved in alterations of striated myocyte Ca2+homeostasis by pipecoloxylidide derivatives, with specific effects of S  -isomers seeming most pronounced in inducing Ca2+release from the SR and in inhibiting reuptake. In addition, at least with regard to Ca2+release from the SR, specific lipophilicity of local anesthetic isomers seems to determine the extent of effects. Therefore, both stereoselectivity and specific lipophilicity are strongly supposed to play an important role in the pathogenesis of local anesthetic myotoxicity.
However, it remains doubtful whether these in vitro  findings are appropriate to explain and determine differences between myotoxic potencies of local anesthetic agents in vivo  . After continuous peripheral nerve blocks, racemic bupivacaine and S  -ropivacaine in equipotent concentrations both induce skeletal muscle fiber necrosis, but racemic bupivacaine causes tissue damage of a significantly larger extent.8 Intriguingly, with regard to our current findings and postulating a relative anesthetic potency of 1.5:1,26 S  -ropivacaine in equipotent concentrations seem more potent in increasing intracellular Ca2+concentrations because specific effects of S  -ropivacaine (15 mm) on both Ca2+release and reuptake exceeded those of racemic bupivacaine (10 mm). This obvious contradiction might be resolved by the fact that because of its pronounced lipophilicity, racemic bupivacaine rapidly perturbs sarcolemmal structures, massively accumulates in the myoplasm, and thus may induce an immediate increase in intracellular Ca2+concentrations in vivo  . Consequently, the effective intracellular concentration of racemic bupivacaine is strongly supposed to be higher than that of less lipophilic S  -ropivacaine as the latter—even when administered in higher, equipotent concentrations—perturbs the sarcolemmal barrier and accumulates intracellularly markedly slower.1,8 Summarizing all these results and findings, we postulate that although tissue damage is likely to be a function of intracellular [Ca2+], it may not be proportional to specific effects on Ca2+regulation assessed in our in vitro  study. Therefore, further studies are warranted to assess the various degrees of skeletal muscle toxicity for all tested compounds and to confirm this hypothesis.
References
Zink W, Graf BM: Local anesthetic myotoxicity. Reg Anesth Pain Med 2004; 29:333–40Zink, W Graf, BM
Gomez-Arnau JI, Yanguela J, Gonzalez A, Andres Y, Garcia del Valle S, Gili P, Fernandez-Guisasola J, Arias A: Anaesthesia-related diplopia after cataract surgery. Br J Anaesth 2003; 90:189–93Gomez-Arnau, JI Yanguela, J Gonzalez, A Andres, Y Garcia del Valle, S Gili, P Fernandez-Guisasola, J Arias, A
Foster AH, Carlson BM: Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesth Analg 1980; 59:727–36Foster, AH Carlson, BM
Hall-Craggs ECB: Early ultrastructural changes in skeletal muscle exposed to local anesthetic bupivacaine (Marcaine). Br J Exp Pathol 1980; 61:139–49Hall-Craggs, ECB
Hogan Q, Dotson R, Erickson S, Kettler R, Hogan K: Local anesthetic myotoxicity: A case and review. Anesthesiology 1994; 80:942–7Hogan, Q Dotson, R Erickson, S Kettler, R Hogan, K
Benoit PW: Reversible skeletal muscle damage after administration of local anesthetics with and without epinephrine. J Oral Surg 1978; 36:198–201Benoit, PW
Benoit PW, Yagiela A, Fort NF: Pharmacologic correlation between local anesthetic-induced myotoxicity and disturbances of intracellular calcium distribution. Toxicol Appl Pharmacol 1980; 52:187–98Benoit, PW Yagiela, A Fort, NF
Zink W, Seif C, Bohl JR, Hacke N, Braun PM, Sinner B, Martin E, Fink RH, Graf BM: The acute myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blockades. Anesth Analg 2003; 97:1173–9Zink, W Seif, C Bohl, JR Hacke, N Braun, PM Sinner, B Martin, E Fink, RH Graf, BM
Zink W, Graf BM, Sinner B, Martin E, Fink RH, Kunst G: Differential effects of bupivacaine on intracellular Ca2+regulation: Potential mechanisms of its myotoxicity. Anesthesiology 2002; 97:710–6Zink, W Graf, BM Sinner, B Martin, E Fink, RH Kunst, G
Zink W, Kunst G, Martin E, Graf BM: Differential effects of S(-)-ropivacaine and bupivacaine on intracellular Ca2+homeostasis in mammalian skeletal muscle fibers (abstract). Anesthesiology 2002; 96:A972Zink, W Kunst, G Martin, E Graf, BM
Maemura Y: Effect of ropivacaine on Ca2+function of skinned skeletal muscle. Masui 2002; 51:19–24Maemura, Y
Kunst G, Stucke AG, Graf BM, Martin E, Fink RHA: Differential effects of sevoflurane, isoflurane, and halothane on Ca2+release from the sarcoplasmic reticulum of skeletal muscle. Anesthesiology 1999; 91:179–86Kunst, G Stucke, AG Graf, BM Martin, E Fink, RHA
Kunst G, Stucke AG, Graf BM, Martin E, Fink RHA: Desflurane induces only minor Ca2+release from the sarcoplasmic reticulum of mammalian skeletal muscle. Anesthesiology 2000; 93:832–6Kunst, G Stucke, AG Graf, BM Martin, E Fink, RHA
Makabe M, Werner O, Fink RHA: The contribution of the sarcoplasmic reticulum Ca2+-transport ATPase to caffeine-induced Ca2+transients of murine skinned skeletal muscle fibers. Pflugers Arch 1996; 432:717–26Makabe, M Werner, O Fink, RHA
Smith GL, Miller DJ: Potentiometric measurements of stoichiometric and apparent affinity constants of EGTA for proton and divalent ions including calcium. Biochim Biophys Acta 1985; 839:287–9Smith, GL Miller, DJ
Zink W, Graf BM, Martin E: Modulation of intracellular calcium homeostasis by tetracaine in skinned skeletal muscle fibers: Reasons for its moderate myotoxicity? Molecular and Basic Mechanisms of Anesthesia. By Urban BW, Barann M. Lengerich, Germany, Pabst Science Publishers, 2002, pp 330–6Zink, W Graf, BM Martin, E Urban BW, Barann M Lengerich, Germany Pabst Science Publishers
Fink RHA, Stephenson DG, Williams DA: Physiological properties of skinned fibers from normal and dystrophic (Duchenne) human muscle activated by Ca2+and Sr2+. J Physiol (Lond) 1990; 420:337–53Fink, RHA Stephenson, DG Williams, DA
Uttenweiler D, Weber C, Fink RHA: Mathematical modelling and fluorescence imaging to study the Ca2+-turnover in skinned muscle fibers. Biophys J 1998; 74:1640–53Uttenweiler, D Weber, C Fink, RHA
Takahashi S: Local anaesthetic bupivacaine alters function of sarcoplasmic reticulum and sarcolemmal vesicles from rabbit masseter muscle. Pharmacol Toxicol 1994; 75:119–28Takahashi, S
Graf BM, Abraham I, Eberbach N, Kunst G, Stowe DF, Martin E: Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physicochemical and stereoselective properties. Anesthesiology 2002; 96:1427–34Graf, BM Abraham, I Eberbach, N Kunst, G Stowe, DF Martin, E
Ford LE, Podolsky RJ: Intracellular calcium movements in skinned muscle fibers. J Physiol (Lond) 1972; 223:21–33Ford, LE Podolsky, RJ
Ashley BC, Barsotti RJ, Lea TJ, Mulligan IP, Tsien RY: Caged-calcium photolysis activates demembraneted muscle fibers from the rabbit. J Physiol 1987; 487:331–42Ashley, BC Barsotti, RJ Lea, TJ Mulligan, IP Tsien, RY
Komai H, Lokuta AJ: Interaction of bupivacaine and tetracaine with the sarcoplasmic reticulum Ca2+release channel of skeletal and cardiac muscles. Anesthesiology 1999; 90:835–43Komai, H Lokuta, AJ
Marks AR: Intracellular calcium-release channels: regulators of cell life and death. Am J Physiol 1997; 272:H597–605Marks, AR
Christensen SB, Andersen A, Poulsen JCJ, Treiman M: Derivates of thapsigargin as probes of its binding site on endoplasmic reticulum Ca2+ATPase: Stereoselectivity and important functional groups. FEBS Lett 1993; 335:345–8Christensen, SB Andersen, A Poulsen, JCJ Treiman, M
Dony P, Dewinde V, Vanderick B: The comparative toxicity of ropivacaine and bupivacaine at equipotent doses in rats. Anesth Analg 2000; 91:1489–92Dony, P Dewinde, V Vanderick, B
Fig. 1. (  A  ) Mean force transients induced by the optical isomers and racemates of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. All force transients are normalized to maximum force transient at 24.9 μm Ca2+. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients induced by tested local anesthetics (  fig. 1A) into corresponding Ca2+transients, based on the individual [Ca2+]–force relation of each fiber. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 1. (  A  ) Mean force transients induced by the optical isomers and racemates of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. All force transients are normalized to maximum force transient at 24.9 μm Ca2+. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients induced by tested local anesthetics (  fig. 1A) into corresponding Ca2+transients, based on the individual [Ca2+]–force relation of each fiber. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 1. (  A  ) Mean force transients induced by the optical isomers and racemates of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. All force transients are normalized to maximum force transient at 24.9 μm Ca2+. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients induced by tested local anesthetics (  fig. 1A) into corresponding Ca2+transients, based on the individual [Ca2+]–force relation of each fiber. *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
×
Fig. 2. (  A  ) Caffeine-induced force transients after loading in the presence of the racemates and isomers of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. In comparison with control transients, all tested agents in concentrations of 5 mm or greater significantly decreased force transients (except  R  -bupivacaine at 5 mm; bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients (  fig. 2A) into corresponding [Ca2+] transients. Again, all tested isomers and racemates, respectively, in concentrations of 5 mm or greater significantly decreased caffeine-induced Ca2+transients in comparison with control values (bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 2. (  A  ) Caffeine-induced force transients after loading in the presence of the racemates and isomers of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. In comparison with control transients, all tested agents in concentrations of 5 mm or greater significantly decreased force transients (except  R  -bupivacaine at 5 mm; bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients (  fig. 2A) into corresponding [Ca2+] transients. Again, all tested isomers and racemates, respectively, in concentrations of 5 mm or greater significantly decreased caffeine-induced Ca2+transients in comparison with control values (bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 2. (  A  ) Caffeine-induced force transients after loading in the presence of the racemates and isomers of ropivacaine and bupivacaine, respectively, in concentrations of 1, 5, 10, and 15 mm. In comparison with control transients, all tested agents in concentrations of 5 mm or greater significantly decreased force transients (except  R  -bupivacaine at 5 mm; bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Transformation of force transients (  fig. 2A) into corresponding [Ca2+] transients. Again, all tested isomers and racemates, respectively, in concentrations of 5 mm or greater significantly decreased caffeine-induced Ca2+transients in comparison with control values (bars not marked for statistical significance). *  P  < 0.05  versus R  -isomer in identical concentrations; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
×
Fig. 3. (  A  ) pCa50values (representing Ca2+sensitivity of the contractile apparatus), assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. No significant differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Hill coefficients n, assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. Again, no obvious differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 3. (  A  ) pCa50values (representing Ca2+sensitivity of the contractile apparatus), assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. No significant differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Hill coefficients n, assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. Again, no obvious differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
Fig. 3. (  A  ) pCa50values (representing Ca2+sensitivity of the contractile apparatus), assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. No significant differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. (  B  ) Hill coefficients n, assessed in the presence of isomers and racemates of bupivacaine and ropivacaine, respectively. Again, no obvious differences were found between experimental groups. *  P  < 0.05 in comparison with control values, assessed in the absence of local anesthetics; §  P  < 0.05  versus  corresponding ropivacaine isomers/racemate in identical concentrations. n = 6 fiber bundle preparations per agents at each concentration. BUP = bupivacaine; ROP = ropivacaine. 
×
Table 1. Experimental Solutions 
Image not available
Table 1. Experimental Solutions 
×
Table 2. Experimental Protocol 
Image not available
Table 2. Experimental Protocol 
×